Martín-Saladich Q, Simó R, Ciudin A, Baguña J, Ramirez-Serra C, Aguadé-Bruix S, Roque A, Pizzi MN, Cuéllar H, Roson-Gradaille N, González Ballester MA, Pericàs JM, Herance JR
Phenotypic patterns of metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: The impact of insulin
Eur J Clin Invest. 2025 Sep;55(9):e70050
DOI: 10.1111/eci.70050
IF: 3.6
RESEARCH GROUPS
Molecular Imaging and Therapy
36
Number of publications
69.44
%
% Q1
38.89
%
% D1
61.11
%
% Leadership
54.55
%
% Female Leadership
2.80
CROWN (2021-2025)
18.83
%
HCP10% (2021-2025)
58.33
%
% Open access
41.67
%
% International Collaboration
10
Highly cited papers / HCP 1% (2021-2025)
4
Publications in high-IF journals with high Altmetric scores
16
Number of Ongoing Projectes (total)
6
International ongoing projects
1
Number of New projects (total)
0
International new projects
1
Number of Active clinical Trials
0
Number of New Clinical Trials
1
Number of Theses
In 2025, the group consolidated its research activities around three strategic areas. First, the development of diagnostic and therapeutic radiopharmaceuticals and targeted molecular therapies, primarily in oncology, with four radiopharmaceutical candidates and two molecular therapies currently under development, as well as two radiopharmaceuticals for ulcerative colitis. Second, digital health and artificial intelligence, focused on generating validated diagnostic and prognostic digital biomarkers, particularly in oncology and metabolic diseases, and on developing algorithms for automated medical image segmentation. Third, infective endocarditis, where the group continues to pioneer innovative imaging-based approaches for non-invasive and personalized diagnosis and management. While also active in fields such as histotripsy, simulation technologies, and telemedicine, these three pillars have delivered the greatest scientific impact, competitive funding, and high-impact publications.
CORE/MISSIONS
- Aging
- AI, Data, Imaging & Digital Health
- Environmental & Public Health
- Innovative & Advanced Therapies
- Rare Diseases
- Transplant & Immunomodulation
PROGRAMS
- Robotic Surgery & Simulation
- Woman, Gender & Diversity Perspective in Health Research
TEAM
Group Leader
José Raul Herance Camacho
Principal Investigator (PI)
José Raúl Herance, Manuel Escobar Amores, Julia Baguña Torres
Researchers
Martha Sahyli Ortega Pijeira, Eser Ucar, Elena Diaz Medina, Ana María Rodríguez Arana, Alberto Roque Pérez, Marc Simó Perdigo, Carles Lorenzo Bosquet, Amparo García Burillo, Ignacio Navales Mateu, Maria Teresa Veintemillas Araiz, Nuria Roson Gradaille, Xavier Merino Casabiel, Lluria Cornellas Escayola, Luis Riera Soler, Ivan Vollmer Torrubiano, Andreu Antolin Redondeo, Stela Svetlozarova Asadurova, Stefania Orlando, Sandra Bondía Bescós, Azahara Maria Palomar Muñoz, Luis Alexander Del Carpio Bellido Vargas, Marta Barios Profitós, Maria De Bonilla Candau, Judith Suils Ramón, Fiorella Paola Dellepiane Clarke, Cristina Gámez Cenzano, Lourdes Rubio Álvarez, Teresa Canella Coll, Ruben Bellviure Meiro, Emilio Mariscal Labrador, Aitor Rodriguez, Almudena Maceda García, Lucia Iglesias Sanchez, M. Àngels Hernandez Fructuoso, Carmen Gloria Franco Monterroso
PhD Students
Carolina Aparicio, Emily Betancourt, Queralt Martín Saladich, Sergi Velasco, Sofia Rodriguez, Marina Llenas, Enrique Franky Vargas, Khadija Hammawa, Alvaro Valverde
SELECTED PUBLICATIONS
Martín-Saladich Q, Pareto D, Simó R, Ciudin A, Aparicio C, Hammawa K, de la Calle Vargas E, Aguadé-Bruix S, Giralt M, Ramirez-Serra C, González Ballester MA, Herance JR
Brain [18F]FDG uptake patterns in type 2 diabetes: new phenotypes relating to biomarkers of cognitive impairment
Brain Commun. 2025 Jun 12;7(3):fcaf213
DOI: 10.1093/braincomms/fcaf213
IF: 6.9
Betancourt Fernández E, Baguña Torres J, Iurlaro R, Cuartas I, Ortega Pijeira MS, Rodríguez Fernández S, Velasco-Vila S, Seoane J, Herance JR.
Development and Preclinical Evaluation of a Zirconium-89-Labeled Immunoconjugate for Positron Emission Tomography Imaging of Leukemia Inhibitory Factor in Glioblastoma
ACS Pharmacol Transl Sci. 2025 Oct 7;8(11):3886-3895
DOI: 10.1021/acsptsci.5c00093
IF: 3.7
Roque A, Pizzi MN
PET/CT in aortic grafts: Sufficient evidence or still leap of faith?
J Nucl Cardiol. 2024 Jun;36:101882
DOI: 10.1016/j.nuclcard.2024.101882
IF: 2.7
Antolin A, Roson N, Planes M, Castillo M, Alberti A, Escobar M
Validation of a tele-robotic ultrasound system for abdomen and thyroid gland explorations: a comparison with standard ultrasound
Ultrasound J. 2025 Jan 13;17(1):2
DOI: 10.1186/s13089-025-00408-6
IF: 2.9
SELECTED PROJECTS
Resistencia a la insulina en la diabetes tipo 2: clarificando el mecanismo patogénico de la resistencia a la insulina miocárdica y los efectos de tratamientos con GLP-1 RA y SGLT2i
Principal Investigator: José Raul Herance Camacho
Agency: Instituto de Salud Carlos III
Funding: 252,500 €
Period: 01/01/2025 - 31/12/2027
ARTEMIs: AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients
Principal Investigator: José Raul Herance Camacho
Agency: EUROPEAN COMMISSION
Funding: 724,000 €
Period: 01/01/2024 - 31/12/2027
Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies
Principal Investigator: José Raul Herance Camacho
Agency: The Innovative Medicines Initiative
Funding: 514,560 €
Period: 01/10/2019 - 31/03/2026
Insulin resistance in type 2 diabetes: unraveling the pathogenic mechanism between organs
Principal Investigator: José Raul Herance Camacho
Agency: Instituto de Salud Carlos III
Funding: 159,720 €
Period: 01/01/2021 - 30/06/2025
UNCAN-Connect: Decentralized Collaborative Network for Advancing Cancer Research and Innovation
Principal Investigator: EUROPEAN COMMISSION
Agency: EUROPEAN COMMISSION
Funding: 300,625 €
Period: 01/09/2025 - 01/09/2030
PATENTS
Reactivos y métodos rápidos para la caracterización de patógenos y pruebas serológicas
Priority Number: 12/06/2020
Priority Date: PCT/EP2020/066292
Applicants: VHIR
DISSEMINATION ACTIVITIES
La Nit de la Recerca 2025
Place: Museu de la Ciència CosmoCaixa de Barcelona
Date: 26/09/2026
Brief: Speed dating 'An X-ray of biomedical research: science from the inside' with the participation of team members.
Women and Girls in Science Day
Place: VHIR
Date: 11/02/2025
Brief: 130 schoolchildren visited the VHIR laboratories, where different scientists explained their research areas with the aim of demystifying the profession.
